-+ 0.00%
-+ 0.00%
-+ 0.00%

Cocrystal Pharma Appoints Carol Brosgart to Board of Directors

PUBT·11/15/2026 12:02:09
Cocrystal Pharma Appoints Carol Brosgart to Board of Directors
  • Cocrystal Pharma appointed Carol Brosgart to its board of directors, effective August 12, 2026.
  • Brosgart spent more than a decade at Gilead Sciences, helping develop antiviral therapies Viread and Hepsera.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611150700PRIMZONEFULLFEED9877746) on November 15, 2026, and is solely responsible for the information contained therein.